FairJourney CEO Hire: Next-Gen AI Sales Trigger
New CEO at FairJourney Biologics. Dr. Werner Lanthaler brings AI-driven focus. 🔥 Accelerate gene-to-clone by 30% and boost deal flow. Hit your quota with this fresh sales trigger.
Published on
Do not index
Do not index
🚀 Battle Card: FairJourney Biologics S.A.
Quick trigger:
Use this FairJourney Biologics S.A. sales trigger to lead with AI-powered discovery.
👤 Decision Maker in the News
- Dr. Werner Lanthaler, Chief Executive Officer · 🔗 [LinkedIn](https://www.linkedin.com/company/fairjourney-biologics/)
💡 Why It Matters
- New CEO with proven track record at Evotec signals push for data- and AI-driven efficiency—classic FairJourney Biologics S.A. sales trigger for pipeline acceleration. → Source
🎯 Core Pain Point
- Aligning scalable, data-driven platforms to accelerate antibody discovery
- Reducing development timelines and costs amid competitive biotech landscape
💰 What to Pitch
- Primary: AI-driven discovery platform → Accelerate "Gene to Clone" cycles by 30%
- Expansion: Global collaboration portal → Enhance partner engagement & data sharing
🗺️ Quick Context
- HQ: Porto, Portugal
- Employees: ≈ 200
- Rev: ≈ $45 M
- Website: [fjbio.com](https://fjbio.com/)
🤼 Competitive Intel
Likely vendors in the ring for this FairJourney Biologics S.A. sales trigger.
- charlesriver.com — Antibody discovery & preclinical services
- Unique edge: End-to-end CRO scale & regulatory expertise
- Evaluated by VP R&D for capability breadth
- evotec.com — Integrated drug discovery platform
- Unique edge: AI-driven precision medicine pipelines
- Evaluated by CSO for innovation potential
- abzena.com — Biologics development CRO
- Unique edge: Modular, flexible capacity with rapid scale-up
- Evaluated by Dir. Bioprocess for timeline adherence
- domainex.co.uk — Drug discovery & medicinal chemistry
- Unique edge: Specialized small molecule & bispecific antibody design
- Evaluated by VP Discovery for custom chemistry support
✅ Do-Now Checklist
Connect with Dr. Werner Lanthaler on LinkedIn (link above)
Craft first touch referencing this FairJourney Biologics S.A. sales trigger & value prop
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑❑
PROOF_METRIC = ❑❑
CTA_STYLE = ❑❑
TONE = ❑❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Werner
COMPANY = FairJourney Biologics S.A.
DEPT = R&D
SIZE = ≈50
BOTTLENECK = scaling data-driven discovery platform
EVENT = New CEO appointment
DETAIL = Appointment of Dr. Werner Lanthaler as CEO
PAIN = reducing development timelines and costs
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251007049277&div=41152219
SIM_CO = Evotec
WIN_METRIC = 30% faster discovery cycles
NEXT_SIZE = ≈100
EMP_EST = ≈200
REV_EST = ≈$45M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈50-person R&D
Werner—noticed your R&D team is ≈50.
That’s when scaling data-driven discovery platform slows growth.
We helped Evotec fix this with .
Result: 30% faster discovery cycles.
Quick call?
PS—next bottleneck hits ≈100.
DM ≤45 words, TONE:
Saw your post about Appointment of Dr. Werner Lanthaler as CEO — reducing development timelines and costs.
. .
Quick chat?```